FDA’s Fast Track Initiative Cut Total Drug Development Time by Three Years
November 13, 2003

Tufts Center for the Study of Drug Development Offers Training to Increase R&D Efficiency
November 10, 2003

Rising Drug Spending Is Spurring Switches of Prescription Drugs to OTC Status in U.S. and Europe
September 3, 2003

Contract Research Organizations Recruiting Globally for Clinical Trials
July 10, 2003

Tufts Center for the Study of Drug Development to Offer Leadership Development Course for Drug Development Teams
June 23, 2003

Total Cost to Develop a New Prescription Drug, Including Cost of Post–Approval Research, is $897 Million
May 13, 2003

Biopharmaceutical Product Approval Times Dropped 21% since the 1980s
March 11, 2003

Over–the–Counter Medicines Will Grow as Patents Expire
January 28, 2003

Biotechnology Manufacturing Set to Realize Dramatic Improvements
January 23, 2003

Tufts Center for the Study of Drug Development Says Increased Demand on the FDA May Lengthen Drug Approval Times
January 13, 2003

Drug Companies Will De–Emphasize Blockbuster Development Strategies
January 6, 2003